Aurobindo Pharma Q2 net profit rises 9%

Quick Summary:

This growth was fueled by an 8% rise in consolidated revenue, driven by a strong performance in formulations, particularly in the US and European markets.

Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore.

However, ARV revenues declined, and API revenues saw a marginal dip.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Swati Bharadwaj

Category: EconomyBusiness

Markets: IndiaOmanPuerto RicoSouth Africa

Topics: Aurobindo Pharma financial results Aurobindo Pharma net profit increase Aurobindo Pharma quarterly earnings Business news Aurobindo Pharma Q2 net profit Aurobindo Pharma formulations revenue

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-10 @ 00:12:15 (3 days ago)

News Timezone: GMT +5:00

News Source URL: timesofindia.indiatimes.com

Language: English

Article Length: 763 words

Reading Time: 5 minutes read

Sentences: 27 lines

Sentence Length: 29 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Times of India

News ID: 23481428

View Article Analysis

About Times of India

Main Topics: EconomyBusiness

Official Website: timesofindia.indiatimes.com

Update Frequency: 27 posts per day

Year Established: 1838

Headquarters: India

News Last Updated: 57 minutes ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #28

Publisher Details

Frequently Asked Questions